Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis

Olivier Govaere, Simon Cockell, DINA G. TINIAKOS et al. · Science Translational Medicine · 2020

, whereas GDF15 supplementation tempered the inflammatory response in macrophages upon lipid loading and lipopolysaccharide stimulation. This study provides insights into the pathophysiology of progressive fibrosing steatohepatitis, and proof of principle that transcriptomic changes represent potentially tractable and clinically relevant markers of disease progression.

Cited by 471 works. doi:10.1126/scitranslmed.aba4448 Open-access PDF

Authors

References